Table 3 Distribution of vaccine dose administration timing following recommended vaccination schedule among children aged 0–59 months
Vaccine Antigens | N | Frequency of vaccination timing following the recommended schedule ((n, (%)) | |||||||
|---|---|---|---|---|---|---|---|---|---|
First week following the recommended schedule | Second week following the recommended schedule | Third week following the recommended schedule | Fourth week following the recommended schedule | 2–5 months following the recommended schedule | 6–11 months following the recommended schedule | More than a year | Number of doses administered before the recommended period | ||
BCG | 382 | 147 (38.5) | 87 (22.8) | 34 (8.9) | 25 (6.5) | 81 (21.2) | 1 (0.3) | 7 (1.8) | 0 (0.0) |
Polio 0 | 359 | 142 (39.6) | 76 (21.2) | 32 (8.9) | 23 (6.4) | 76 (21.2) | 0 (0.0) | 10 (2.9) | 0 (0.0) |
DPT-Hi + Hb 1 | 360 | 142 (39.4) | 55 (15.3) | 23 (6.4) | 20 (5.6) | 47 (13.1) | 3 (0.8) | 3 (0.8) | 67 (18.6) |
DPT-Hi + Hb 2 | 315 | 80 (25.4) | 61 (19.4) | 30 (9.5) | 23 (7.3) | 72 (22.9) | 4 (1.3) | 2 (0.6) | 43 (13.7) |
DPT-Hi + Hb 3 | 268 | 44 (16.4) | 44 (16.4) | 33 (12.3) | 13 (6.3) | 85 (31.7) | 7 (2.6) | 4 (1.5) | 34 (12.7) |
Polio 1 | 345 | 141 (40.9) | 49 (14.2) | 22 (6.4) | 19 (5.5) | 45 (13.0) | 2 (0.6) | 3 (0.9) | 64 (18.6) |
Polio 2 | 300 | 76 (25.3) | 62 (20.7) | 28 (9.3) | 25 (8.3) | 65 (21.7) | 3 (1.0) | 2 (0.7) | 39 (13.0) |
Polio 3 or VPI | 259 | 39 (15.1) | 43 (16.6) | 35 (13.5) | 20 (7.7) | 78 (30.1) | 4 (1.5) | 2 (0.8) | 38 (14.7) |
Measle rubella or Measles | 154 | 20 (13.0) | 27 (17.5) | 23 (14.9) | 12 (7.8) | 45 (29.2) | 3 (1.9) | 1 (0.6) | 23 (14.9) |